Abiopharma

Estrella Immunopharma Announces Closing of $8.0 Million Registered Direct Offering and Concurrent Private Placement

Xreal Air 2 Pro: Latest Info and Updates

New Form 424B5 - Estrella Immunopharma, Inc. Filed: 2026-01-06 AccNo: 0001213900-26-001686 Size: 356 KB

Why Is Fortnite Not Working? Troubleshooting Steps To Try

(85% Positive) PROFOUND MEDICAL CORP. (PROF) Provides Update on advancement for prostate care

Ziihera® (zanidatamab-hrii) Combinations Achieve Unprecedented Results in First-Line HER2+ Locally Advanced or Metastatic GEA including more than Two Years Median Overall Survival Benefit

(70% Positive) AIxCrypto Holdings, Inc. (QLGN) Announces Business Combination

Ziihera® (zanidatamab-hrii) Combinations Achieve Unprecedented Results in First-Line HER2+ Locally Advanced or Metastatic GEA Including More Than Two Years Median Overall Survival Benefit

Alvotech (ALVOW) Files Form 6-K

Inside the Smart India Hackathon: Innovation, Impact, and the Power of Youth in Problem-Solving

GENFIT: Favorable Phase 1 Safety Profile and Strong Anti-Inflammatory Activity for ACLF Lead Asset G1090N

📋 Guyer William (Officer) plans to sell 20K shares of CORCEPT THERAPEUTICS INC (at $34.95 each, total $699K) Filed: Jan 06, 2026 | ID: 000003

Corcept Therapeutics (CORT) Faces Investor Scrutiny Amid Receipt of FDA Complete Response Letter For Relacorilant, Shares Tank 50% - Hagens Berman

📋 Blanchfield Paul (Ex-Officer) plans to sell 7K shares of Lantheus Holdings, Inc. (at $69.53 each, total $502K) Filed: Jan 06, 2026 | ID: 000134

HALEON PLC (HLN) Files Form 6-K